This article is more than 5 years old. Information may no longer be current.

CooperVision to acquire Sauflon

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Cooper Companies Inc. announced Monday that it has reached an agreement to acquire Sauflon Pharmaceuticals Ltd.

As detailed in the release from Cooper, the purchase, valued at about $1.2 billion, is expected to close by the end of the fiscal year on Oct. 31, as it is subject to regulatory approval.

“We are extremely pleased to announce this acquisition, which gives CooperVision the world’s most comprehensive portfolio of daily disposable lenses," Robert S. Weiss, Cooper’s president and CEO, said in the release. "CooperVision will now be able to offer a multitier daily strategy that includes a full suite of silicone hydrogel and hydrogel lenses, including options within all categories – spheres, torics and multifocals.

“The daily segment is the fastest growing segment of the soft contact lens market,” Weiss continued, “and this transaction positions CooperVision as the premier company in this space.”

The transaction will be financed with credit facilities and off-shore cash, according to the release. Sauflon forecasts revenue of about $210 million for its fiscal year ending Oct. 31, up about 22% year-over-year, Cooper said in the release.